These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 27050667)

  • 1. Lowering methodological standards for studies of multidrug-resistant bacteria is counterproductive.
    Paul M; Hussein K
    Clin Microbiol Infect; 2016 Jun; 22(6):497-8. PubMed ID: 27050667
    [No Abstract]   [Full Text] [Related]  

  • 2. Late stage antibacterial drugs in the clinical pipeline.
    Projan SJ; Bradford PA
    Curr Opin Microbiol; 2007 Oct; 10(5):441-6. PubMed ID: 17950658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An emerging multidrug-resistant bacteria.
    Johnstone J; Patel SN;
    CMAJ; 2017 Sep; 189(35):E1115. PubMed ID: 28874433
    [No Abstract]   [Full Text] [Related]  

  • 4. Difficulties in demonstrating superiority of an antibiotic for multidrug-resistant bacteria in nonrandomized studies.
    Stafford KA; Boutin M; Evans SR; Harris AD
    Clin Infect Dis; 2014 Oct; 59(8):1142-7. PubMed ID: 24982037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multidrug-resistant bacteria require new treatment options].
    Panknin HT
    Med Monatsschr Pharm; 2015 Dec; 38(12):517-21. PubMed ID: 26837160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studying new antibiotics for multidrug resistant infections: are today's patients paying for unproved future benefits?
    Powers JH; Evans SR; Kesselheim AS
    BMJ; 2018 Feb; 360():k587. PubMed ID: 29472192
    [No Abstract]   [Full Text] [Related]  

  • 7. [Microbiological approach to antibiotic therapy against multidrug-resistant bacteria].
    Kusachi S
    Nihon Geka Gakkai Zasshi; 2003 Jul; 104(7):527-9. PubMed ID: 12884778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The challenge of antibiotic resistant bacterial pathogens: the medical need, the market and prospects for new antimicrobial agents.
    Payne D; Tomasz A
    Curr Opin Microbiol; 2004 Oct; 7(5):435-8. PubMed ID: 15451496
    [No Abstract]   [Full Text] [Related]  

  • 9. Selecting empiric antibiotic therapy in an era of multi-drug resistance--is the cupboard really bare? Introduction.
    Collatz E
    Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():1. PubMed ID: 19040460
    [No Abstract]   [Full Text] [Related]  

  • 10. Predicting antibiotic resistance.
    Martínez JL; Baquero F; Andersson DI
    Nat Rev Microbiol; 2007 Dec; 5(12):958-65. PubMed ID: 18007678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fosfomycin--its significance for treatment of diseases due to multidrug-resistant bacteria].
    Stock I
    Med Monatsschr Pharm; 2015 Jan; 38(1):4-11. PubMed ID: 26349119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in the management of serious infections.
    Rehm SJ; Bartlett JG
    Clin Infect Dis; 2006 Jan; 42 Suppl 2():S63-4. PubMed ID: 16355318
    [No Abstract]   [Full Text] [Related]  

  • 13. New β-lactam antibiotics and β-lactamase inhibitors.
    Bush K; Macielag MJ
    Expert Opin Ther Pat; 2010 Oct; 20(10):1277-93. PubMed ID: 20839927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does microbial resistance matter?
    Vincent JL
    Lancet Infect Dis; 2011 Jan; 11(1):3-4. PubMed ID: 21126916
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel antibiotics: are we still in the pre-post-antibiotic era?
    Draenert R; Seybold U; Grützner E; Bogner JR
    Infection; 2015 Apr; 43(2):145-51. PubMed ID: 25701222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Losing ground: multidrug-resistant bacteria in solid-organ transplantation.
    Herati RS; Blumberg EA
    Curr Opin Infect Dis; 2012 Aug; 25(4):445-9. PubMed ID: 22766649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metal nanobullets for multidrug resistant bacteria and biofilms.
    Chen CW; Hsu CY; Lai SM; Syu WJ; Wang TY; Lai PS
    Adv Drug Deliv Rev; 2014 Nov; 78():88-104. PubMed ID: 25138828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whither antibacterial drug discovery?
    Projan SJ
    Drug Discov Today; 2008 Apr; 13(7-8):279-80. PubMed ID: 18405838
    [No Abstract]   [Full Text] [Related]  

  • 19. Combination approaches to combat multidrug-resistant bacteria.
    Worthington RJ; Melander C
    Trends Biotechnol; 2013 Mar; 31(3):177-84. PubMed ID: 23333434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug-resistant organisms and antibiotic management.
    Barie PS
    Surg Clin North Am; 2012 Apr; 92(2):345-91, ix-x. PubMed ID: 22414417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.